Paul R. Mouncey

Paul R. Mouncey

Auto-generated profile, based on publicly available information

Paul R. Mouncey

Clinical Trials Unit, Intensive Care National Audit & Research Centre, London, United Kingdom

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2015 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PMPaul R Mouncey
Paul R Mouncey
TOTiffany M Osborn
Tiffany M Osborn
GPG Sarah Power
G Sarah Power
DHDavid Harrison
David Harrison
MSM Zia Sadique
M Zia Sadique
PIProMISe Trial Investigators
ProMISe Trial Investigators
Early, goal-directed therapy (EGDT) is recommended in international guidelines for the resuscitation of patients presenting with early septic shock. However, adoption has been limited, and uncertainty about its effectiveness remains.

8 June 2017 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PIPRISM Investigators
PRISM Investigators
KRKathryn M Rowan
Kathryn M Rowan
DADerek C Angus
Derek C Angus
MBMichael Bailey
Michael Bailey
ABAmber E Barnato
Amber E Barnato
DYDonald M Yealy
Donald M Yealy
After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septic shock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit. This meta-analysis of individual patient data from the three recent trials was designed prospectively to improve statistical power and explore heterogeneity of treatment effect of EGDT.


30 June 2022 in New England Journal of Medicine
Verified
Journal Article
Closed access
TMTine S. Meyhoff
Tine S. Meyhoff
PHPeter B. Hjortrup
Peter B. Hjortrup
JWJørn Wetterslev
Jørn Wetterslev
PSPraleene Sivapalan
Praleene Sivapalan
JLJon H. Laake
Jon H. Laake
APAnders Perner
Anders Perner
Intravenous fluids are recommended for the treatment of patients who are in septic shock, but higher fluid volumes have been associated with harm in patients who are in the intensive care unit (ICU).

9 October 2020 in Intensive Care Medicine
Verified
Journal Article
Open access
PDF file
ARAlvin Richards-Belle
Alvin Richards-Belle
IOIzabella Orzechowska
Izabella Orzechowska
DGDoug Gould
Doug Gould
KTKaren Thomas
Karen Thomas
JDJames Doidge
James Doidge
MSMichelle Saull
Michelle Saull
Purpose To describe critical care patients with COVID-19 across England, Wales and Northern Ireland and compare them with a historic cohort of patients with other viral pneumonias (non-COVID-19) and with international cohorts of COVID-19. Methods Extracted data on patient characteristics, acute illness severity, organ support and outcomes from the Case Mix Programme, the national clinical audit for adult critical care, for a prospective cohort of patients with COVID-19 (February to August 2020) are compared with a recent retrospective cohort of patients with other viral pneumonias (non-COVID-19) (2017–2019) and with other international cohorts of critical care patients with COVID-19, the latter identified from published reports. Results 10,834 patients with COVID-19 (70.1% male, median age 60 years, 32.6% non-white ethnicity, 39.4% obese, 8.2% at least one serious comorbidity) were admitted across 289 critical care units. Of these, 36.9% had a PaO2/FiO2 ratio of ≤ 13.3 kPa (≤ 100 mmHg) consistent with severe ARDS and 72% received invasive ventilation. Acute hospital mortality was 42%, higher than for 5782 critical care patients with other viral pneumonias (non-COVID-19) (24.7%), and most COVID-19 deaths (88.7%) occurred before 30 days. Meaningful international comparisons were limited due to lack of standardised reporting. Conclusion Critical care patients with COVID-19 were disproportionately non-white, from more deprived areas and more likely to be male and obese. Conventional severity scoring appeared not to adequately reflect their acute severity, with the distribution across PaO2/FiO2 ratio categories indicating acutely severe respiratory disease. Critical care patients with COVID-19 experience high mortality and place a great burden on critical care services.

1 March 2021 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Open access
JDJames Doidge
James Doidge
DGDoug Gould
Doug Gould
PFPaloma Ferrando-Vivas
Paloma Ferrando-Vivas
PMPaul R. Mouncey
Paul R. Mouncey
KTKaren Thomas
Karen Thomas
KRKathryn M. Rowan
Kathryn M. Rowan
Rationale: By describing trends in intensive care for patients with coronavirus disease (COVID-19) we aim to support clinical learning, service planning, and hypothesis generation. Objectives: To describe variation in ICU admission rates over time and by geography during the first wave of the epidemic in England, Wales, and Northern Ireland; to describe trends in patient characteristics on admission to ICU, first-24-hours physiology in ICU, processes of care in ICU and patient outcomes; and to explore deviations in trends during the peak period. Methods: A cohort of 10,741 patients with COVID-19 in the Case Mix Program national clinical audit from February 1 to July 31, 2020, was used. Analyses were stratified by time period (prepeak, peak, and postpeak periods) and geographical region. Logistic regression was used to estimate adjusted differences in 28-day in-hospital mortality between periods. Measurements and Main Results: Admissions to ICUs peaked almost simultaneously across regions but varied 4.6-fold in magnitude. Compared with patients admitted in the prepeak period, patients admitted in the postpeak period were slightly younger but with higher degrees of dependency and comorbidity on admission to ICUs and more deranged first-24-hours physiology. Despite this, receipt of invasive ventilation and renal replacement therapy decreased, and adjusted 28-day in-hospital mortality was reduced by 11.8% (95% confidence interval, 8.7%–15.0%). Many variables exhibited u-shaped or n-shaped curves during the peak. Conclusions: The population of patients with COVID-19 admitted to ICUs, and the processes of care in ICUs, changed over the first wave of the epidemic. After adjustment for important risk factors, there was a substantial improvement in patient outcomes.